| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1d385ec863ef8c79eafa6bad345da60e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_379a600b6d7f336a460fafea157cec22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_71413c88350b22f773bd745eb773acfe |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-1205 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-12 |
| filingDate |
2003-09-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2bf2c93c6e01144724aa4443f973335d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_115cfe86e7f4de7787de5149ebe123f7 |
| publicationDate |
2004-03-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2004022592-A1 |
| titleOfInvention |
Use of human protein kinase c-eta in methods for identification of pharmaceutically useful agents |
| abstract |
The invention relates to the use of the human Protein Kinase Cη (PKC-eta) isoform, in methods for identification of pharmaceutically useful agents, in particular agents useful for the treatment of type 2 diabetes. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007123233-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110520144-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2007089546-A |
| priorityDate |
2002-09-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |